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Carl Linnaeus published one of the most important early
disease classifications in 1759, classifying a total of 325
diseases into 11 classes and 37 orders. This work, Genera
morborum, provided a source of inspiration for a number
of other classifications which paved the way for the clas-
sification of Bertillon in 1891 that subsequently became
the first edition of the International Classification of
Diseases (ICD). The latest edition of the ICD (ICD-10),
includes nearly 500 rare diseases, only about 240 of
which have a specific ICD code. With roughly 8000
named RDs and at least 100 new RDs characterized
yearly, this means that less than 3% of RDs have codes in
the ICD-10. Correspondingly, rare diseases have been
largely invisible in national mortality and morbidity sta-
tistics, and policy makers have tended to allocate much
fewer resources for research and clinical care in the field
of rare diseases than might be expected given their over-
all prevalence of at least 5% of the population.
The new edition of the ICD (ICD-11, which is due by
2015) offers an opportunity to address these shortcomings.
A Topic Advisory Group on Rare Diseases chaired by
Ségolène Aymé has been coordinating efforts to create a
comprehensive classification (nosology) of rare diseases
for the new ICD. The classification is to follow a primarily
clinical approach, and a polyhierarchy approach is used to
include rare diseases affecting several body systems are
included in each relevant chapter.
Phenotype ontologies such as the Human Phenotype
Ontology complement disease classifications by providing
a tool to describe and analyze the spectrum of signs, symp-
toms, and other abnormalities that people with the disease
in question may display. A large number of different
vocabularies and ontologies for human phenotype have
been developed for different goals and users, but it will be
essential to improve interoperability between these ter-
minologies in the future in order to make maximum use of
all available resources.
Classifications, ontologies, and other computational
resources for human disease and phenotype will allow
more accurate statistics about prevalence of rare diseases,
better allocation of health care resources, and an improved
ability to perform computational analysis of human disease
manifestations for differential diagnosis and clinical deci-
sion support systems. Additionally, they will provide a
basis for deep phenotype analysis to characterize the nat-
ural history of rare diseases and to discover clinically
actionable complications and risks.
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